Intrinsic Value

The intrinsic value of Guerbet SA (4G8) under the Base Case is 11.71 EUR per share. Compared with the current market price of 5.33 EUR, the stock appears Undervalued by 54% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

4G8 Intrinsic Value
€11.71
Undervaluation 54%
Intrinsic Value
Price €5.33

4G8 is cheaper than usual. This is its cheapest valuation in the past 5 years.

Monitor 4G8
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €9.37
Get notified when the price drops into your buy zone
Intrinsic Value €11.71
Margin of Safety 20% €9.37
Current Price €5.33
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to 4G8

Fundamental Analysis

What Guerbet Does

Health Care

Guerbet SA makes medical contrast products and imaging equipment used in radiology. Its core products help doctors make X-ray, CT, MRI, and interventional imaging scans clearer so they can spot disease, guide procedures, and improve diagnosis. The company also sells related injector systems and software that work with these contrast agents and imaging workflows.

Headquarters
France FR
Employees
2 700
IPO date
Jan 15, 1986
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Guerbet SA

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one 4G8 stock?

The intrinsic value for Guerbet SA (4G8) under the Base Case is 11.71 EUR.

Is 4G8 stock undervalued or overvalued?

Compared with the current market price of 5.33 EUR, the stock appears Undervalued by 54% .

Back to Top